每經AI快(kuai)訊(xun)，申(shen)聯(lian)生(sheng)(sheng)(sheng)物（SH 688098，收盤(pan)價(jia)：8.13元）1月3日晚(wan)間發布公(gong)(gong)(gong)(gong)告稱，同(tong)(tong)時，高艷(yan)(yan)春(chun)女士(shi)(shi)因(yin)(yin)個人(ren)原因(yin)(yin)申(shen)請(qing)辭(ci)去(qu)公(gong)(gong)(gong)(gong)司(si)(si)董(dong)(dong)(dong)事以及(ji)董(dong)(dong)(dong)事會(hui)(hui)(hui)專業委員會(hui)(hui)(hui)的(de)(de)職務(wu)，楊從(cong)州先(xian)生(sheng)(sheng)(sheng)因(yin)(yin)工(gong)作調整申(shen)請(qing)辭(ci)去(qu)公(gong)(gong)(gong)(gong)司(si)(si)副(fu)總(zong)(zong)(zong)(zong)經(jing)理職務(wu)，聶文豪(hao)(hao)先(xian)生(sheng)(sheng)(sheng)因(yin)(yin)工(gong)作調整申(shen)請(qing)辭(ci)去(qu)公(gong)(gong)(gong)(gong)司(si)(si)董(dong)(dong)(dong)事會(hui)(hui)(hui)秘書(shu)職務(wu)。辭(ci)職后，高艷(yan)(yan)春(chun)女士(shi)(shi)不(bu)再在公(gong)(gong)(gong)(gong)司(si)(si)擔(dan)(dan)任(ren)任(ren)何職務(wu)，楊從(cong)州先(xian)生(sheng)(sheng)(sheng)仍(reng)擔(dan)(dan)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)董(dong)(dong)(dong)事，聶文豪(hao)(hao)先(xian)生(sheng)(sheng)(sheng)仍(reng)擔(dan)(dan)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)董(dong)(dong)(dong)事、副(fu)總(zong)(zong)(zong)(zong)經(jing)理。截至(zhi)本公(gong)(gong)(gong)(gong)告披露(lu)日，高艷(yan)(yan)春(chun)女士(shi)(shi)持有公(gong)(gong)(gong)(gong)司(si)(si)股份27萬股。公(gong)(gong)(gong)(gong)司(si)(si)審(shen)議(yi)(yi)(yi)(yi)通過(guo)了(le)《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)聘(pin)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)總(zong)(zong)(zong)(zong)經(jing)理的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)聘(pin)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)常務(wu)副(fu)總(zong)(zong)(zong)(zong)經(jing)理的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)聘(pin)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)技(ji)術總(zong)(zong)(zong)(zong)監的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)聘(pin)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)董(dong)(dong)(dong)事會(hui)(hui)(hui)秘書(shu)的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)延(yan)長其(qi)他高級管理人(ren)員任(ren)期的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》。經(jing)公(gong)(gong)(gong)(gong)司(si)(si)董(dong)(dong)(dong)事長聶東(dong)升先(xian)生(sheng)(sheng)(sheng)提名，第三屆(jie)董(dong)(dong)(dong)事會(hui)(hui)(hui)提名委員會(hui)(hui)(hui)2022年第二次會(hui)(hui)(hui)議(yi)(yi)(yi)(yi)審(shen)查通過(guo)，審(shen)議(yi)(yi)(yi)(yi)通過(guo)了(le)《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)聘(pin)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)總(zong)(zong)(zong)(zong)經(jing)理的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)聘(pin)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)常務(wu)副(fu)總(zong)(zong)(zong)(zong)經(jing)理的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)聘(pin)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)技(ji)術總(zong)(zong)(zong)(zong)監的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)聘(pin)任(ren)公(gong)(gong)(gong)(gong)司(si)(si)董(dong)(dong)(dong)事會(hui)(hui)(hui)秘書(shu)的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》《關(guan)(guan)(guan)于(yu)(yu)(yu)(yu)延(yan)長其(qi)他高級管理人(ren)員任(ren)期的(de)(de)議(yi)(yi)(yi)(yi)案(an)(an)》。同(tong)(tong)時公(gong)(gong)(gong)(gong)司(si)(si)董(dong)(dong)(dong)事會(hui)(hui)(hui)同(tong)(tong)意將現任(ren)副(fu)總(zong)(zong)(zong)(zong)經(jing)理聶文豪(hao)(hao)先(xian)生(sheng)(sheng)(sheng)以及(ji)財務(wu)總(zong)(zong)(zong)(zong)監李瑞(rui)玲女士(shi)(shi)的(de)(de)任(ren)期一并延(yan)長至(zhi)第三屆(jie)董(dong)(dong)(dong)事會(hui)(hui)(hui)任(ren)期屆(jie)滿之日止。由於海霞女士(shi)(shi)繼續(xu)兼任(ren)證券(quan)事務(wu)代表至(zhi)聘(pin)任(ren)新(xin)的(de)(de)證券(quan)事務(wu)代表為止。

2021年1至(zhi)12月份，申(shen)聯生物的營(ying)業收入構成為：獸用生物制品占(zhan)比99.82%。

截至發(fa)稿，申聯生(sheng)物市值為33億元。

道達號（daoda1997）“個股趨勢”提醒：
1. 近30日內無機構對申聯生物進行調研；
2. 申聯生物上一次發布人事變動公告是2022年11月30日，申聯生物近一年共發布4次人事變動公告。
更多(duo)個股趨勢信息，請搜索微信公眾號(hao)“道達(da)號(hao)”，回復“查詢(xun)(xun)”，領取免費查詢(xun)(xun)權限(xian)！

每經頭條(tiao)（nbdtoutiao）——

(記者 蔡鼎)

免(mian)責(ze)聲(sheng)明：本(ben)文內容與(yu)數據(ju)(ju)僅(jin)供參考，不構成投資建議(yi)，使(shi)用前(qian)請核實。據(ju)(ju)此操作，風險自(zi)擔。